Skip to main content

Table 1 Clinico-pathological patient characteristics of the gastric cancer validation cohort

From: Interpreting whole genome and exome sequencing data of individual gastric cancer samples

Patient characteristics
Patients   [n] 482
Age [years]   [mean ± SD] 67.9 ± 11.1
  median 68
Gender Men [n (%)] 297 (61.6)
Women [n (%)] 185 (38.4)
Follow-up data Alive [n (%)] 131 (28.1)
Dead [n (%)] 335 (71.9)
Localization Proximal [n (%)] 149 (30.9)
Distal [n (%)] 333 (69.1)
pT-category pT1a [n (%)] 13 (2.7)
pT1b [n (%)] 49 (10.2)
pT2 [n (%)] 56 (11.6)
pT3 [n (%)] 190 (39.4)
pT4a [n (%)] 134 (27.8)
pT4b [n (%)] 40 (8.3)
pN-category pN0 [n (%)] 138 (28.8)
pN1 [n (%)] 67 (14.0)
pN2 [n (%)] 85 (17.7)
pN3/a/b [n (%)] 189 (39.5)
UICC Stage (7th ed.) IA [n (%)] 49 (10.4)
IB [n (%)] 32 (6.8)
IIA [n (%)] 58 (12.3)
IIB [n (%)] 47 (9.9)
IIIA [n (%)] 55 (11.6)
IIIB [n (%)] 83 (17.5)
IIIC [n (%)] 66 (14.0)
IV [n (%)] 83 (17.5)
Stage according to I [n (%)] 49 (10.2)
Kiel proposal II [n (%)] 84 (17.5)
IIIA [n (%)] 49 (10.2)
IIIB [n (%)] 153 (31.9)
IV [n (%)] 145 (30.2)
Resected lymph nodes   [mean ± SD] 19.2 ± 8.2
  median [n] 18
Positive lymph nodes   [mean ± SD] 6.4 ± 7.4
  median [n] 3
Lymph node ratio (LNR)   median [n] 0.2
Tumor grade G1 / G2 [n (%)] 111 (23.7)
G3 / G4 [n (%)] 357 (76.3)
Resection margin (R-status) R0 [n (%)] 403 (88.2)
R1/R2 [n (%)] 54 (11.8)